Jennison Associates’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-383,714
| Closed | -$22.7M | – | 682 |
|
|
2021
Q3 | $22.7M | Sell |
383,714
-360,278
| -48% | -$21.4M | 0.01% | 343 |
|
|
2021
Q2 | $64.6M | Hold |
743,992
| – | – | 0.04% | 178 |
|
|
2021
Q1 | $61.3M | Sell |
743,992
-31,365
| -4% | -$2.59M | 0.04% | 187 |
|
|
2020
Q4 | $70.5M | Sell |
775,357
-240,712
| -24% | -$21.9M | 0.05% | 153 |
|
|
2020
Q3 | $40.6M | Buy |
1,016,069
+3,644
| +0.4% | +$146K | 0.03% | 216 |
|
|
2020
Q2 | $34.7M | Sell |
1,012,425
-106,950
| -10% | -$3.67M | 0.03% | 217 |
|
|
2020
Q1 | $24.9M | Sell |
1,119,375
-187,631
| -14% | -$4.17M | 0.03% | 226 |
|
|
2019
Q4 | $25.6M | Buy |
1,307,006
+7,638
| +0.6% | +$149K | 0.03% | 276 |
|
|
2019
Q3 | $20.2M | Buy |
1,299,368
+751,446
| +137% | +$11.7M | 0.02% | 317 |
|
|
2019
Q2 | $11.1M | Buy |
547,922
+60,878
| +12% | +$1.24M | 0.01% | 423 |
|
|
2019
Q1 | $8.56M | Buy |
487,044
+253,540
| +109% | +$4.45M | 0.01% | 439 |
|
|
2018
Q4 | $3M | Sell |
233,504
-66,496
| -22% | -$853K | ﹤0.01% | 495 |
|
|
2018
Q3 | $4.89M | Buy |
+300,000
| New | +$4.89M | ﹤0.01% | 498 |
|